INDAGA · COVERAGE MAP

What Indaga screens

Curated clinical panels, a whole-genome pathogenic screen, and a graded interpretation universe — mapped, with every gene↔panel connection.
0
named-panel genes
0
genes shared across panels
0
gene–disease validity
0
polygenic scores

The genome coverage ring

Every panel and its sub-panels, sized by gene count. Hover a segment; click to expand its genes, provenance & source link.

Hover or click the ring

Panel provenance and gene list appear here. Center = de-duplicated union.

The gene ↔ panel network

The interconnection: bright nodes are hub genes shared across many panels. Hover to trace links; click a gene or panel to focus; drag to explore; search a gene.
shared genes only reset
Tip: hover MLH1 or COMT — they sit in 5 panels each.
Top hub genes — click to trace:

How the tiers overlap

The same gene often matters clinically and for wellness — one engine, all three tiers.

Chip vs sequencing — what the data can actually see

Coverage isn't one number. Chip+imputation is strong on common variants, near-blind on rare ones.
~90%
Chip · wellness layer
nutrigenetics · PGx · PGS · traits
~2%
Chip · rare-clinical
ACMG / carrier pathogenic (rare)
~99%
Sequencing (WES/WGS)
the honest upsell for the rest

Per-person coverage — measured, not assumed

On a panel ≠ callable in you ≠ a finding. Indaga screens broadly but reports, per person, which genes its data could read — “not measured” is never “negative.”